<VariationArchive VariationID="2856619" VariationName="NM_020989.4(CRYGC):c.475dup (p.Ala159fs)" VariationType="Duplication" Accession="VCV002856619" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-19" DateCreated="2024-02-20" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3017518" VariationID="2856619">
      <GeneList>
        <Gene Symbol="CRYGC" FullName="crystallin gamma C" GeneID="1420" HGNC_ID="HGNC:2410" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q33.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="208128137" stop="208129828" display_start="208128137" display_stop="208129828" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_018654710.1" start="126431" stop="137394" display_start="126431" display_stop="137394" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="208992860" stop="208994553" display_start="208992860" display_stop="208994553" Strand="-" />
          </Location>
          <OMIM>123680</OMIM>
          <Haploinsufficiency last_evaluated="2013-05-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CRYGC">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-05-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CRYGC">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC100507443" FullName="uncharacterized LOC100507443" GeneID="100507443" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q33.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="208119129" stop="208156762" display_start="208119129" display_stop="208156762" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_018654710.1" start="117423" stop="135497" display_start="117423" display_stop="135497" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_020989.4(CRYGC):c.475dup (p.Ala159fs)</Name>
      <CanonicalSPDI>NC_000002.12:208128252:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q33.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="208128252" stop="208128253" display_start="208128252" display_stop="208128253" variantLength="1" positionVCF="208128252" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="208992976" stop="208992977" display_start="208992976" display_stop="208992977" variantLength="1" positionVCF="208992976" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>A159fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.208992982dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.208992982dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.208128258dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.208128258dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008038.1" sequenceAccession="NG_008038" sequenceVersion="1" change="g.6578dup">
            <Expression>NG_008038.1:g.6578dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008039.1" sequenceAccession="NG_008039" sequenceVersion="1" change="g.1337dup">
            <Expression>NG_008039.1:g.1337dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020989.4" sequenceAccession="NM_020989" sequenceVersion="4" change="c.475dup" MANESelect="true">
            <Expression>NM_020989.4:c.475dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066269.1" sequenceAccession="NP_066269" sequenceVersion="1" change="p.Ala159fs">
            <Expression>NP_066269.1:p.Ala159fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020989.3" sequenceAccession="NM_020989" sequenceVersion="3" change="c.475dupG">
            <Expression>NM_020989.3:c.475dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020989.4(CRYGC):c.475dup (p.Ala159fs) AND Nuclear pulverulent cataract" Accession="RCV003759200" Version="1">
        <ClassifiedConditionList TraitSetID="48307">
          <ClassifiedCondition DB="MedGen" ID="C1852438">Nuclear pulverulent cataract</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-15" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020989.4(CRYGC):c.475dup (p.Ala159fs) AND CRYGC-related disorder" Accession="RCV003901272" Version="1">
        <ClassifiedConditionList TraitSetID="91735">
          <ClassifiedCondition>CRYGC-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-30" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2024-02-20" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-03-14">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="48307" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="28624" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Nuclear pulverulent cataract</ElementValue>
                <XRef ID="HP:0010698" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CTRCT2</ElementValue>
                <XRef ID="GTR000553198" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <XRef ID="C1852438" DB="MedGen" />
              <XRef Type="primary" ID="HP:0010698" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="91735" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">CRYGC-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CRYGC-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8245570" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="21299923|MedGen:C1852438" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004455416" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with CRYGC-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala159Glyfs*5) in the CRYGC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 16 amino acid(s) of the CRYGC protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CRYGC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.208992976_208992977insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="C1852438" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8799628" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="26160527|CRYGC-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004712627" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CRYGC c.475dupG variant is predicted to result in a frameshift and premature protein termination (p.Ala159Glyfs*5). This variant occurs within the terminal exon of the CRYGC gene, near the stop codon. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At PreventionGenetics, we have detected this variant in another patient with childhood-onset cataracts (Internal Data). Frameshift variants in CRYGC are expected to be pathogenic and have been documented both up- and downstream of amino acid 159 in individuals with cataracts (Human Gene Mutation Database). This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CRYGC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020989.3:c.475dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CRYGC-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8245570" TraitType="Finding" MappingType="XRef" MappingValue="C1852438" MappingRef="MedGen">
        <MedGen CUI="C1852438" Name="Nuclear pulverulent cataract" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8799628" TraitType="Disease" MappingType="Name" MappingValue="CRYGC-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="CRYGC-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

